HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2-methyl-4-phenyl-(4-pyridyl)oxazole

inhibits p38 mitogen-activated protein kinase (p38 MAPK); structure in first source

Also Known As:

SC 68376; SC-68376

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Oxazoles: 89
      - 2-methyl-4-phenyl-(4-pyridyl)oxazole: 1
  - Pyridines: 88
    - 2-methyl-4-phenyl-(4-pyridyl)oxazole: 1

Experts

1.	Dierkes, Christian: 1 article (03/2003)
2.	Eisenhardt, Nils: 1 article (03/2003)
3.	Ermert, Leander: 1 article (03/2003)
4.	Ermert, Monika: 1 article (03/2003)
5.	Kuttner, Daniel: 1 article (03/2003)
6.	Seeger, Werner: 1 article (03/2003)

Related Diseases

1.	Edema (Dropsy) 03/01/2003 - "Two unrelated selective inhibitors of p38 (SB203580 and SC-68376) dose dependently suppressed the arachidonic acid-induced pulmonary artery pressor response, edema formation, and bronchoconstrictor response in both control lungs and lungs that underwent preceding endotoxin priming. "

Related Drugs and Biologics

1.	Arachidonic Acid (Vitamin F)
2.	Endotoxins
3.	SB 203580